Biogen's CSO Quietly Leaves, But Will Still Get R&D Funding From the Biotech Giant

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-scientist5.jpg" NAME"Biogen's CSO Quietly Leaves, But Will Still Get R&D Funding From the Biotech Giant" ALT"Biogen's CSO Quietly Leaves, But Will Still Get R&D Funding From the Biotech Giant"May…

Continue ReadingBiogen's CSO Quietly Leaves, But Will Still Get R&D Funding From the Biotech Giant

Safety Concerns Raised as Ionis Pharma's Inotersen Meets Both Primary Endpoints in Late-Stage Study

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"Safety Concerns Raised as Ionis Pharma's Inotersen Meets Both Primary Endpoints in Late-Stage Study" ALT"Safety Concerns Raised as Ionis Pharma's Inotersen Meets Both Primary Endpoints in Late-Stage Study"May…

Continue ReadingSafety Concerns Raised as Ionis Pharma's Inotersen Meets Both Primary Endpoints in Late-Stage Study